The Latest Breaking News on Pharma

The World Health Organization and the U.S. Centers for Disease Control and Prevention say measles immunization has dropped significantly since the coronavirus pandemic began, resulting in a record high of nearly 40 million children missing a vaccine dose last year

Documents suggest husband passed on money from PPE Medpro, which secured £200m contracts after Mone lobbied ministers

Here are some of the key moments from the last two days, as the South African President’s visit to the UK continues.

Biotech company Bionano Genomics (BNGO) has beaten analysts’ top-line estimate in the third quarter. However, its cash and cash equivalents balance has declined year-over-year. Therefore, is it a buy now under $3? Read on to find out….

Trying to avert a heavy surge in respiratory illnesses, California’s leading public health officials once again stressed on Tuesday that state residents should do all they can to prevent the spread of COVID-19, the flu and respiratory syncytial virus, or RSV, as they gather for the holidays.

"The harms of paramilitarism are much broader and will need a tailored and very different process."

Hemgenix frees patients from repeated treatments but initial cost makes it most expensive medicine in the world

Eight districts in the central Chinese city of Zhengzhou will conduct mass COVID-19 testing for five consecutive days from Nov. 25, state television CCTV reported on Wednesday.

Among the more remarkable legacies of the COVID-19 pandemic is how quickly federal regulators, the health care industry and consumers moved to make at-home testing a reliable tool for managing a public health crisis.

Biopharmaceutical major Bristol-Myers Squibb Company (BMY) beat the consensus earnings and revenue estimates in the third quarter. Given its strong product pipeline, strategic acquisitions, discounted valuation, high profitability, strong financials, and attractive dividends, investors could buy the stock now. Read more….

Britain and South Africa on Wednesday announced a new health and science partnership to mark the second day of President Cyril Ramaphosa's state visit to London, the first such official guest hosted by Britain's King Charles.